Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.23 MXN | -2.37% |
|
+0.93% | -14.87% |
| Market Cap | 14.85B 851M 743M 682M 636M 1.21B 80.97B 1.23B 8.22B 3.18B 39.72B 3.19B 3.12B 137B | P/E 2026 * |
6.94x | P/E 2027 * | 6.86x |
|---|---|---|---|---|---|
| Enterprise Value | 18.71B 1.07B 936M 860M 802M 1.52B 102B 1.55B 10.35B 4.01B 50.04B 4.02B 3.94B 172B | EV / Sales 2026 * |
1.02x | EV / Sales 2027 * | 0.95x |
| Free-Float |
68.95% | Yield 2026 * |
5.26% | Yield 2027 * | 7.21% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -2.37% | ||
| 1 week | +0.93% | ||
| Current month | +1.33% | ||
| 1 month | -2.12% | ||
| 3 months | -18.90% | ||
| 6 months | -15.06% | ||
| Current year | -14.87% |
| 1 week | 14.65 | 15.7 | |
| 1 month | 14.24 | 15.7 | |
| Current year | 14.24 | 19.48 | |
| 1 year | 14.24 | 23.6 | |
| 3 years | 12.39 | 29.18 | |
| 5 years | 12.39 | 29.18 | |
| 10 years | 11.1 | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 2023-04-11 |
| Director of Finance/CFO | - | 2015-11-30 | |
| Investor Relations Contact | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1996-10-29 | |
Juan Alonso
BRD | Director/Board Member | - | 2010-07-05 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.37% | +0.93% | -26.35% | +15.38% | 868M | ||
| +1.86% | +7.65% | +55.77% | +158.84% | 1,063B | ||
| +3.57% | +7.42% | +69.09% | +58.92% | 611B | ||
| +3.99% | +7.37% | +36.87% | +93.77% | 444B | ||
| -1.20% | -1.94% | +26.41% | +20.22% | 324B | ||
| +4.94% | +3.39% | +39.92% | +28.93% | 285B | ||
| +2.42% | +1.60% | +30.06% | +42.24% | 283B | ||
| +2.47% | +5.18% | -24.80% | -39.60% | 219B | ||
| +3.55% | +6.05% | +26.04% | +68.52% | 195B | ||
| +4.21% | +6.00% | +17.72% | +70.33% | 156B | ||
| Average | +1.87% | +4.02% | +25.07% | +51.75% | 358.16B | |
| Weighted average by Cap. | +1.85% | +5.08% | +41.53% | +80.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.32B 1.05B 917M 842M 785M 1.49B 99.88B 1.51B 10.14B 3.93B 48.99B 3.94B 3.85B 169B | 19.24B 1.1B 963M 884M 824M 1.56B 105B 1.59B 10.64B 4.12B 51.44B 4.14B 4.05B 177B |
| Net income | 2.14B 122M 107M 98.17M 91.55M 174M 11.65B 176M 1.18B 458M 5.71B 459M 449M 19.69B | 2.25B 129M 113M 103M 96.44M 183M 12.27B 186M 1.25B 483M 6.02B 484M 473M 20.74B |
| Net Debt | 3.86B 221M 193M 177M 165M 314M 21.05B 319M 2.14B 828M 10.33B 830M 812M 35.58B | 3.46B 198M 173M 159M 148M 281M 18.88B 286M 1.92B 743M 9.26B 745M 729M 31.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | MX$15.23 | -2.37% | 3,487,891 |
| 26-07-01 | MX$15.60 | +3.79% | 3,977,498 |
| 26-06-30 | MX$15.03 | +0.80% | 6,164,745 |
| 26-06-29 | MX$14.91 | -0.33% | 2,412,960 |
| 26-06-26 | MX$14.96 | -0.86% | 3,986,049 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions

















